63 related articles for article (PubMed ID: 22456450)
1. Novel application of EEG source localization in the assessment of the penumbra.
Phan TG; Gureyev T; Nesterets Y; Ma H; Thyagarajan D
Cerebrovasc Dis; 2012; 33(4):405-7. PubMed ID: 22456450
[No Abstract] [Full Text] [Related]
2. Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis.
Maiser SJ; Georgiadis AL; Suri MF; Vazquez G; Lakshminarayan K; Qureshi AI
Int J Stroke; 2011 Feb; 6(1):25-32. PubMed ID: 21205237
[TBL] [Abstract][Full Text] [Related]
3. Young women have poorer outcomes than men after stroke.
Martínez-Sánchez P; Fuentes B; Fernández-Domínguez J; Ortega-Casarrubios Mde L; Aguilar-Amar MJ; Abenza-Abildúa MJ; Idrovo-Freire L; Díez-Tejedor E
Cerebrovasc Dis; 2011; 31(5):455-63. PubMed ID: 21346351
[TBL] [Abstract][Full Text] [Related]
4. Rapid EEG changes indicate reperfusion after tissue plasminogen activator injection in acute ischaemic stroke.
Finnigan SP; Rose SE; Chalk JB
Clin Neurophysiol; 2006 Oct; 117(10):2338-9. PubMed ID: 16926108
[No Abstract] [Full Text] [Related]
5. Improved cerebral pathophysiology immediately following thrombectomy in acute ischaemic stroke: Monitoring via quantitative EEG.
Schleiger E; Wong A; Read S; Coulthard A; Finnigan S
Clin Neurophysiol; 2016 Aug; 127(8):2832-2833. PubMed ID: 27417059
[No Abstract] [Full Text] [Related]
6. Magnetic resonance imaging-guided thrombolysis in minor stroke.
Desilles JP; Cho TH; Hermier M; Mechtouff-Cimarelli L; Derex L; Nighoghossian N
Int J Stroke; 2011 Apr; 6(2):178. PubMed ID: 21371285
[No Abstract] [Full Text] [Related]
7. Imaging helps identify who benefits from stroke intervention.
Yuh WT; Taoka T; Ueda T; Chaloupka JC
Diagn Imaging (San Franc); 1999 Dec; 21(12):77-82. PubMed ID: 10724845
[No Abstract] [Full Text] [Related]
8. Failure of a clot retrieval device in an adolescent stroke patient.
Felker MV; Zimmer JA; Golomb MR
Pediatr Neurol; 2010 Dec; 43(6):435-8. PubMed ID: 21093737
[TBL] [Abstract][Full Text] [Related]
9. Intravenous thrombolysis based on diffusion-weighted imaging and fluid-attenuated inversion recovery mismatch in acute stroke patients with unknown onset time.
Aoki J; Kimura K; Iguchi Y; Shibazaki K; Iwanaga T; Watanabe M; Kobayashi K; Sakai K; Sakamoto Y
Cerebrovasc Dis; 2011; 31(5):435-41. PubMed ID: 21346348
[TBL] [Abstract][Full Text] [Related]
10. Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.
Casado Naranjo I; Portilla-Cuenca JC; Jiménez Caballero PE; Calle Escobar ML; Romero Sevilla RM
Cerebrovasc Dis; 2011; 32(6):614-5. PubMed ID: 22133608
[No Abstract] [Full Text] [Related]
11. Arterial occlusion sites on magnetic resonance angiography influence the efficacy of intravenous low-dose (0.6 mg/kg) alteplase therapy for ischaemic stroke.
Nakashima T; Toyoda K; Koga M; Matsuoka H; Nagatsuka K; Takada T; Naritomi H; Minematsu K
Int J Stroke; 2009 Dec; 4(6):425-31. PubMed ID: 19930051
[TBL] [Abstract][Full Text] [Related]
12. Magnetoencephalography is more successful for screening and localizing frontal lobe epilepsy than electroencephalography.
Ossenblok P; de Munck JC; Colon A; Drolsbach W; Boon P
Epilepsia; 2007 Nov; 48(11):2139-49. PubMed ID: 17662061
[TBL] [Abstract][Full Text] [Related]
13. Hyperglycemia during ischemia rapidly accelerates brain damage in stroke patients treated with tPA.
Ribo M; Molina CA; Delgado P; Rubiera M; Delgado-Mederos R; Rovira A; Munuera J; Alvarez-Sabin J
J Cereb Blood Flow Metab; 2007 Sep; 27(9):1616-22. PubMed ID: 17299452
[TBL] [Abstract][Full Text] [Related]
14. Tissue plasminogen activator use in a patient with acute ischemic stroke coexisting with meningioma.
Hsieh HC; Chen CH
Clin Neurol Neurosurg; 2009 Jul; 111(6):562-3. PubMed ID: 19200644
[No Abstract] [Full Text] [Related]
15. MRI-based ultrafast protocol thrombolysis with rt-PA for acute ischemia stroke in 12-hour time window.
Li YH; Li MH; Zhao JG; Wang W
J Neuroimaging; 2011 Oct; 21(4):332-9. PubMed ID: 21121996
[TBL] [Abstract][Full Text] [Related]
16. Stroke therapy strategy change: how to achieve neuroprotection.
Braun JS
Int J Stroke; 2010 Jun; 5(3):234. PubMed ID: 20536621
[No Abstract] [Full Text] [Related]
17. Failed recovery from thrombolysis is predicted by the initial diffusion weighted imaging lesion.
Seitz RJ; Oberstrass H; Ringelstein A; Wittsack HJ; Siebler M
Cerebrovasc Dis; 2011; 31(6):580-7. PubMed ID: 21487223
[TBL] [Abstract][Full Text] [Related]
18. Treating acute ischemic stroke.
Fisher M; Bastan B
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):626-32. PubMed ID: 18729014
[TBL] [Abstract][Full Text] [Related]
19. Human recombinant tissue-plasminogen activator (alteplase): why not use the 'human' dose for stroke studies in rats?
Haelewyn B; Risso JJ; Abraini JH
J Cereb Blood Flow Metab; 2010 May; 30(5):900-3. PubMed ID: 20216551
[TBL] [Abstract][Full Text] [Related]
20. Is penumbral imaging useful for extending the treatment window for intravenous tissue plasminogen activator?
Fisher M
Ann Neurol; 2006 Nov; 60(5):499-501. PubMed ID: 17120251
[No Abstract] [Full Text] [Related]
[Next] [New Search]
